Sageworth Trust’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-460
Closed -$18K – 536
2021
Q4
$18K Sell
460
-1,532
-77% -$69.8K ﹤0.01% 196
2021
Q3
$100K Hold
1,992
– – 0.01% 116
2021
Q2
$111K Hold
1,992
– – 0.01% 148
2021
Q1
$93K Buy
+1,992
New +$96.5K 0.01% 125

Other funds holding HCAT

Sageworth Trust's HCAT Position: Q1 2022 in Review

Sageworth Trust sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 460 shares — an estimated $18K sold.

Sageworth Trust first reported a position in HCAT in Q1 2021 and held it in 4 quarters. The position peaked at $111K in Q2 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Sageworth Trust reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • Sageworth Trust sold 460 Health Catalyst shares in Q1 2022, an estimated $18K.
  • Sageworth Trust first reported a position in Health Catalyst in Q1 2021 and held it in 4 quarters.
  • Sageworth Trust's Health Catalyst position peaked at $111K in Q2 2021.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Sageworth Trust's 13F filing for Q1 2022, filed 6 May 2022.